OF CUSTOMER SATISFACTION SURVEYS (0910-0360)
The generic clearance will only be used for customer satisfaction and website usability surveys where FDA seeks to gather information that is planned for internal use only and can provide a justification for qualitative or anecdotal collections that may nonetheless produce useful information for program and service improvement.
TITLE OF INFORMATION COLLECTION: FDA Food Industry Survey for Coronavirus Disease 2019 (COVID-19) Related Materials
DESCRIPTION OF THIS SPECIFIC COLLECTION
Statement of need:
The Food and Drug Administration (FDA) has developed several guidances, checklists, and other tools to help food facilities safely continue operations and prevent potential disruptions in food supply chains during the COVID-19 pandemic. The voluntary FDA Food Industry Customer Satisfaction Survey for COVID-19 Related Materials would enable FDA to: (1) determine customer awareness of, and satisfaction with, FDA’s COVID-19 related guidances and other tools for the food industry; (2) identify and monitor trends around specific areas of satisfaction or dissatisfaction; (3) identify and address areas of unmet need; and (4) identify process improvements to increase the quality of FDA’s customer service.
Supporting references include:
Intended use of information:
Results from the survey will be used to improve FDA resources for regulated food facilities that may be experiencing COVID-19 related impacts on operations. We also intend to use the results of the survey to enhance our outreach, improve our engagement with stakeholders, and better disseminate information to food facilities during the COVID-19 pandemic. The information collection will be used for these internal purposes and will not to influence policy or rulemaking.
Description of respondents:
Respondents will be FDA-registered food facilities in areas that are experiencing a rise in COVID-19 cases or in areas that are expected to experience a rise in COVID-19 cases.
Date(s) to be conducted:
FDA plans to launch the telephone survey on December 7, 2020, and will proceed until a maximum of 15,000 registered food facilities are contacted during the COVID-19 pandemic. FDA is seeking OMB approval for this collection by no later than December 1, 2020.
How the Information is being collected:
Surveys will be conducted by FDA personnel contacting respondents by telephone and administering a short survey.
Confidentiality of Respondents:
Data will be kept secure to the fullest extent allowed by law.
The script includes the following statement, which will be read to participants:
“This call is not pre-announcing any inspections and is not a part of a regulatory inspection. Your participation or nonparticipation is completely voluntary. Your responses do not affect your eligibility for receipt of any FDA services and will not have an effect on future FDA inspections or your facility’s compliance status.”
Amount and justification for any proposed incentive
There is no proposed incentive
being offered for completing this voluntary survey.
Questions
of a Sensitive Nature (Data will be kept private to the extent
allowed by the law)
There are no questions of a sensitive nature being asked on the survey.
Description of Statistical Methods
The sample size for the survey is based on the number of FDA-regulated food facilities located in areas that are experiencing a rise in COVID-19 cases or in areas that are expected to experience a rise in COVID-19 cases. FDA will be conducting surveys of up to 15,000 FDA-regulated facilities and expects that at least 70% of the food facilities contacted will complete the survey. The information will be collected on a web-based form and analyzed using FDA computers.
BURDEN HOUR COMPUTATION:
Based on experience, FDA anticipates conducting 15,000 surveys a year. The survey takes approximately 10 minutes to complete (2,500 burden hours/year).
Type/Category of Respondent |
No. of Respondents |
Participation Time (minutes) |
Burden (hours) |
Food Industry |
15,000 |
10 |
2,500 |
REQUESTED APPROVAL DATE: December 1, 2020
NAME OF PRA ANALYST & PROGRAM CONTACT:
Ila S. Mizrachi
Paperwork Reduction Act Staff
301-796-7726
Ila.Mizrachi@fda.hhs.gov
Charlotte Christin
202-306-9390
Charlotte.Christin@fda.hhs.gov
FDA CENTER: Office of the Commissioner/Office of Food Policy and Response
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | OMBMemoMERCPtP |
Subject | MERC OMB MEP |
Author | Hillabrant |
File Modified | 0000-00-00 |
File Created | 2021-11-06 |